Review the evolution of trial design for research in ALS

Consider the challenges in conducting trials in ALS 

Discuss the guidelines that impact clinical trial design in ALS 

Discuss outcome measures for clinical trials in ALS 

In this module, Angele Genge, MD provides a review of the evolution of trial design for research in ALS. This content is supported by Mitsubishi Tanabe Pharma America (MTPA). MTPA employees do not have access to the MedShr platform. Please email&nbsp;<a href="mailto:info@medshr.net" target="_blank" rel="noopener noreferrer" class="editor-link">info@medshr.net</a>&nbsp;if you would like further information.

Module 9: Clinical Trials Design in ALS 

Amyotrophic Lateral Sclerosis — ALS Academy supported by MTPA

Amyotrophic Lateral Sclerosis

The ALS Academy is a comprehensive, on-line, educational platform that provides healthcare professionals with a clinically relevant understanding of the disease. Eight top medical experts in ALS in North America created this educational series, with 10 modules spanning key topics in ALS.

This content is supported by Mitsubishi Tanabe Pharma America (MTPA). MTPA employees do not have access to the MedShr platform. Please email info@medshr.net if you would like further information.

ALS Education

Module 1: Introduction to ALS

Module 2: Clinical Features of ALS

Module 3: Diagnosis of ALS

Module 4: Tracking ALS Disease Progression

Module 6: Clinical Management of ALS: Part 2

Module 7: Genetics of ALS

Module 8: Pathophysiology of ALS

Module 10: Real World Experience in ALS

The ALS Academy is a comprehensive, on-line, educational platform that provides healthcare professionals with a clinically relevant understanding of the disease. Eight top medical experts in ALS in North America created this educational series, with 10 modules spanning key topics in ALS. This content is supported by Mitsubishi Tanabe Pharma America (MTPA). MTPA employees do not have access to the MedShr platform. Please email&nbsp;<a href="mailto:info@medshr.net" target="_blank" rel="noopener noreferrer" class="editor-link">info@medshr.net</a>&nbsp;if you would like further information.